About Us

GEL TECHNOLOGY FOR HEALTHCARE, NUTRITION & PERFORMANCE

An evolution in oral drug and nutrient delivery

Gelteq specialises in the formulation, development and manufacturing of products utilising our patented, gel-based oral drug delivery system. We are dedicated to delivering products that contribute to the success of our partners, and the health of our patients.

ORAL DELIVERY FOR THE 21ST CENTURY

Our Mission

Gelteq is dedicated to developing and deploying our gel-based drug delivery system, to preserve the simplicity, accessibility and efficacy of oral delivery – without the impediments traditionally associated with other oral delivery methods.


Today we continue to expand the application of our gel technology within: pharmaceutical, pet and veterinary, nutritional, and sports performance sectors.

MOVING FORWARD

Partners and Collaborations

Gelteq is always on the lookout for partnering and collaboration opportunities that will help accelerate a partner’s product innovation. We continuously develop new products in partnership with pharmaceutical, commercial, and academic institutions. We are also actively seeking opportunities to license existing formulations and market-ready products. The structures of these licenses can be tailored to meet our partners’ need and preferences.

Learn More

Jan 2018

New Diabetes-based gel products developed with Medicines Manufacturing Innovation Centre at Monash University, Monash Institute of Pharmaceutical Sciences (MIPS).

Dec 2020

Global COVID-19 lockdowns has enabled more R&D, creating additional products ready for immediate commercialisation.

research, pHARMA AND COMMERCIAL partners

Research and formulation partners

MIPS Partnership

Formulation Partners

A FLEXIBLE, FUNCTIONAL AND TARGETED EDIBLE GEL

About Monash University

Monash’s MMIC is Gelteq’s full-time research and development partner. This leading institute was formed as a partnership between Monash University, the Monash Institute of Pharmaceutical Science, and the Victorian state government to create a world-class biotechnology and medical research precinct. Its global clients include GSK, Phillips, Roche and Pfizer.